Imidazoles as potential antifungal agents: A review

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 11, 2013, Pages 1626-1655

  Rani, Nidhi ^a   Sharma, Ajay ^a   Gupta, Girish Kumar ^b   Singh, Randhir ^b  

^a Himalayan Institute of Pharmaceutical Sciences   (India)

^b MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

Antifungal agent; Antimycotic agent; Imidazole; Structure activity relationship study

Indexed keywords

(E) L (5 CHLOROTHIEN 2 YL) 2 (1H IMIDAZOL L YL)ETHANONE 2,6 DICHLOROPHENYL HYDRAZONE HYDROCHLORIDE; (Z) 2 (DIETHYLAMINO) ETHYL 4 ((1H IMIDAZOL 2 YL)DIAZENYL)BENZOATE; 1 (4 BIPHENYLYL) 3 [(1H IMIDAZOL 1 YL)METHYL] 1 PROPAN 1 ONE; 1 [(ARYL)(4 ARYL 1H PYRROL 3 YL)METHYL] 1H IMIDAZOLE; 1 [1 [2 [(3 CHLOROBENZYL)OXY]PHENYL]VINYL] 1H IMIDAZOLE HYDROCHLORIDE; 1 [2 (2,4 DICHLOROPHENYL) 2 (3,7 DIMETHYL 2,6 OCTADIENYLOXY)ETHYL] 1H IMIDAZOLE; 1 [4 (4 CHLOROPHENYL) 2 (2,6 DICHLOROPHENYLTHIO) N BUTYL] 1H IMIDAZOLE NITRATE; 1(4 METHOXY 2 HYDROXYPHENYL) 2 (1H IMIDAZOL 1 YL)ETHANONE; 3 ARYL 4 [ALPHA (1H IMIDAZOL L YL)ARYLMETHYL]PYRROLE DERIVATIVE; 3 PHENYL 1 (1,1 BIPHENYL 4 YL) 2 (1H IMIDAZOL 1 YL)PROPANE DERIVATIVE; BIFONAZOLE; CLOTRIMAZOLE; EBERCONAZOLE; ECONAZOLE; ENILCONAZOLE; FENTICONAZOLE; IMIDAZOLE DERIVATIVE; KETOCONAZOLE; LANOCONAZOLE; LOMBAZOLE; METHYL 4 OXO 4 (IMIDAZOLE PHENYLAMINO)BUTANOATE; MICONAZOLE; N [(1,1 BIPHENYL) 4 YLMETHYL] N [(2,4 DICHLOROPHENYL)METHYL] 1H IMIDAZOL 1 AMINE; PARCONAZOLE; SERTACONAZOLE; SULCONAZOLE; TINIDAZOLE; TIOCONAZOLE; TRIFLUOROACETAMIDE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; AGAR DIFFUSION; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; DERMATOPHYTOSIS; DRUG BIOAVAILABILITY; ERYTHRASMA; FUNGAL STRAIN; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; PERMEABILITY; PHASE 3 CLINICAL TRIAL (TOPIC); SEBORRHEIC DERMATITIS; SKIN CANDIDIASIS; SKIN INFECTION; STRUCTURE ACTIVITY RELATION; TINEA PEDIS; TINEA VERSICOLOR; VAGINA CANDIDIASIS; VAGINA DISCHARGE;

ANTIFUNGAL AGENTS; FUNGI; HUMANS; IMIDAZOLES; MYCOSES; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84888024664     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/13895575113139990069     Document Type: Article

References (231)

1. Eduard, W. Fungal spores: A critical review of the toxicological and epidemiological evidence as a basis for occupational exposure limit setting. Critical Reviews in Toxicology, 2009, 39(10), 799-864.
2. Shao, P.; Huanga, L.; Hsueh, P. Recent advances and challenges in the treatment of invasive fungal infections. International Journal of Antimicrobial Agents, 2007, 30, 487-495.
3. Hay, R. J. Fungal infections. Clinics in Dermatology, 2006, 24, 201-212.
4. Raghavan, R.; Date, A.; Bhaktaviziam, A. Fungal and nocardial infections of the kidney. Histopathology, 1987, 11, 9-20.
5. Gupta, K. L. Fungal infections and the kidney. Indian J. Nephrol, 2001, 11, 147-154.
6. Blanco, J. L.; Garcia, M. E. Immune response to fungal infections. Veterinary Immunology and Immunopathology, 2008, 125, 47-70.
7. McDonnell, M. Fungal infections in the newborn. Semin Neonatal, 1996, 1, 141-145.
8. Bellina, F.; Cauteruccio, S.; Rossi, R. Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles. Tetrahedron, 2007, 63, 4571-4624.
9. Grimmett, M. R. Comprehensive Heterocyclic Chemistry II; Katritsky, A. R., Scriven, E. F. V., Eds.; Pergamon: Oxford, 1996, 3, 77-220.
10. Boiani, M.; González, M. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini-Reviews Med. Chem, 2005, 5, 409-424.
11. Wright, S. W.; Harris, R. R.; Collins, R. J.; Corbett, R. L.; Green, A. M.; Wadman, E. A.; and Batt, D. G. Novel l-(Pyridylphenyl)-lphenyl-2-imidazolyl ethanols with topical antiinflammatory activity. J. Med. Chem, 1992, 35, 3148-3155.
12. 3-receptor antagonists. Eur. J. Pharm. Sci, 2002, 15, 367-378.
13. Soujanya, Y.; Sastry, G. N. Theoretical elucidation of the antioxidant mechanism of 1, 3-dihydro-1-methyl-2H-imidazole-2-selenol (MSeI). Tetrahedron Letters, 2007, 48, 2109-2112.
14. Nguyen, D. N.; Stump, C. A.; Walsh, E. S.; Fernandes, C.; Davide, J. P.; Ellis-Hutchings, M.; Robinson, R. G.; Williams, T. M.; Lobell, R. B.; Huber H. E.; Buser, C. A. Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorg. Med. Chem. Lett, 2002, 12, 1269-1273.
15. Chen, J.; Wang, Z.; Lu, Y.; Dalton, J. T.; Millera, D. D.; Li, W. Synthesis and antiproliferative activity of imidazole and imidazoline analogues for melanoma. Bioorg. Med. Chem. Lett, 2008, 18, 3183-3187.
16. Das, P.; Himaja, M. Design and synthesis of 4-[2-(5-Nitro)]imidazolylbenzoyl(N-methyl) aminoacids and peptides. Int. J. Drug Develop. Res, 2010, 2(2), 364-370.
17. Ferreira, S. B.; Costa, M. S.; Boechat, N.; Bezerra, R. J. S.; Genestra, M. S.; Canto-Cavalheiro, M. M.; Kover, W. B.; Ferreira, V. F. Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents. Eur. J. Med. Chem, 2007, 42, 1388-1395.
18. Valdez, C. A.; Tripp, J. C.; Miyamoto, Y.; Kalisiak, J.; Hruz, P.; Andersen, Y. S.; Brown, S. E.; Kangas, K.; Arzu, L. V.; Davds, B. J.; Gillin, F. D.; Upcroft, J. A.; Upcroft, P.; Fokin, V. V.; Smith, D. K.; Sharpless, K. B.; Eckmann, L. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-Nitroimidazole and antimicrobial activity against Giardia lamblia. J. Med. Chem, 2009, 52, 4038-4053.
19. Dominianni, S. J.; Yen, T. T. Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides. J. Med. Chem, 1989, 32, 2301-2306.
20. Sennequier, N.; Wolan, D.; Stuehr, D. Antifungal imidazoles block assembly of inducible no synthase into an active dimer. J. Biol. Chem, 1999, 274(2), 930-938.
21. Brogden, R. N.; Heel, R. C.; Speight, T. M.; Avery, G. S. Metronidazole in anaerobic infections: A review of its activity, pharmacokinetics and therapeutic use. Drugs, 1978, 16, 387-417.
22. Niwano, Y.; Seo, A.; Kanai, K.; Hamaguchi, H.; Uchida, K.; Yamaguchi, H. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs. Antimicrob. Agents Chemother, 1994, 38, 2204-2206.
23. Botta, M.; Corelli, F.; Gasparrini, F.; Messina, F.; Mugnaini, C. Chiral azole derivatives. 4. Enantiomers of Bifonazole and related antifungal agents: Synthesis, configuration assignment, and biological evaluation. J. Org. Chem, 2000, 65, 4736-4739.
24. Jain, R.; Vangapandu, S.; Jain, M.; Kaur, N.; Singh, S.; Singh, P. P. Antimalarial activities of ring-substituted bioimidazoles. Bioorg. Med. Chem. Lett, 2002, 12, 1701-1704.
25. Brimblecombe, R. W.; Duncan, W. A. M.; Durant, G. J.; Emmett, J. C.; Gannellin, C. R.; Parsons, M. E. J. Int. Med. Res, 1975, 3, 86-92.
26. Ucucu, U.; Karaburun, N. G.; Isikdag, I. Synthesis and analgesic activity of some 1-benzyl-2-substituted-4, 5-diphenyl-1H-imidazole derivatives. Il Farmaco, 2001, 56, 285-290.
27. Mano, T.; Stevens, R. W.; Ando, K.; Nakao, K.; Okumura, Y.; Sakakibara, M.; Okumura, T.; Tamura, T.; Miyamoto, K. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase. Bioorg. Med. Chem, 2003, 11, 3879-3887.
28. 1 receptor antagonists related to SR141716. Bioorg. Med. Chem. Lett, 2004, 14, 1151-1154.
29. 2 receptor antagonists with high binding efficiencies. Bioorg. Med. Chem. Lett, 2010, 20, 1084-1089.
30. Kiselyov, A. S.; Semenova, M.; Semenov, V. V. Hetaryl imidazoles: A novel dual inhibitors of VEGF receptors I and II. Bioorg. Med. Chem. Lett, 2006, 16, 1440-1444.
31. Blum, C. A.; Zheng, X.; De Lombaert, S. Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1Himidazoles: Potent and selective neuropeptide Y5-receptor antagonists. J. Med. Chem, 2004, 47, 2318-2325.
32. Jackson, P. F.; Bullington, J. L. Pyridinylimidazole based p38 MAP kinase inhibitors. Curr. Top. Med. Chem, 2002, 2, 1011-1020.
33. Wilson, K. P.; McCaffrey, P. G.; Hsiao, K.; Pazhanisamy, S.; Galullo, V.; Bemis, G. W.; Fitzgibbon, M. J.; Caron, P. R.; Murcko, M. A.; Su, M. S. S. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol, 1997, 4, 423-431.
34. Bolos, J. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors. Mini-Rev. Med. Chem, 2005, 5, 857-868.
35. Diller, D. J.; Lin, T. H.; Metzger, A. The discovery of novel chemotypes of p38 kinase inhibitors. Curr. Top. Med. Chem, 2005, 5, 953-965.
36. th ed.; Lippincott-Williams and Wilkins, 1998.
37. Coura, J. R.; de Castro, S. L. Mem. A critical review on chagas disease chemotherapy. Inst. Oswaldo Cruz, 2002, 97, 3-24.
38. Dhinaut, A.; Tizot, A.; Rambaud, E.; Lockhart, B.; Lestage, P.; Goldstein, S. Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones. J Med. Chem, 2000, 43, 2165-2175.
39. Khan, Z. K.; Jain, P. Antifungal agents and immunomodulators in systemic mycoses. The Indian J. Chest Dis. Allied Sci, 2000, 42, 345-355.
40. Croxtall, J. D.; Plosker, G. L. Sertaconazole-A review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs, 2009, 69 (3), 339-359.
41. Sud, I. J.; Feingold, D. S. Heterogeneity of action of mechanisms among antimycotic imidazoles. Antimicrob. Agents Chemother, 1981, 20, 71-74.
42. Odds F. C. Antifungal agents: Their diversity and increasing sophistication. Mycologist, 2003, 17(2), 51-55.
43. Marriott, M. S. Inhibition of sterol biosynthesis in C. albicans by imidazole-containing antifungals. J. Gen. Microb, 1980, 117, 253-255.
44. Borgers, M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev. Infect. Dis, 1980, 2(4), 520-534.
45. Heel, R. C.; Brogden, R. N.; Pakes, G. E.; Speight, T. M.; Avery, G. S. Miconazole: A preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs, 1980, 19(1), 7-30.
46. Heel, R. C.; Brogden, R. N.; Carmine, A.; Morley, P. A.; Speight, T. M.; Avery, G. S. Ketoconazole: A review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs, 1982, 23(1-2), 1-36.
47. Cupp-Vickery, J. R.; Garcia, C.; Hofacre, A.; McGee-Estrada, K. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF. J. Mol. Biol, 2001, 311, 101-110.
48. th edition; Wileyinterscience A John Wiley and Sons, Inc., Publication, 2003.
49. th edition; Lippincott-Williams and Wilkins, 2008.
50. Sud, I. J.; Chou, D. L.; Feingold, D. S. Effect of free fatty acids on liposome susceptibility to imidazole antifungals. Antimicrob. Agents Chemother, 1979, 16(5), 660-663.
51. Clissold, S. P.; Heel, R. C. Tioconazole: A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs, 1986, 31(1), 29-51.
52. Mahmoudabadi, A. Z.; Drucker, D. B. Effect of Amphotericin B, Nystatin and Miconazole on the polar lipids of C. albicans and C. dubliniensis. Indian J. Pharm, 2006, 38(6), 423-426.
53. Vanden, B. H.; Engelen, M.; Rochette, F. Antifungal agents of use in animal health-chemical, biochemical and pharmacological aspects. J. vet. Pharmacol. Therap, 2003, 26, 5-29.
54. Niwano, Y.; Tabuchi, T.; Kanai, K.; Hamaguchi, H.; Uchida, K.; Yamaguchi, H. Short-term topical therapy of experimental Tinea pedis in guinea pigs with Lanoconazole, a new imidazole antimycotic agent. Antimicrob. Agents Chemother, 1995, 39(10), 2353-2355.
55. Niwano, Y.; Ohmi T.; Seo, A.; Kodama, H.; Koga, H.; Sakai, A. Lanoconazole and its related optically active compound NND-502: Novel antifungal imidazoles with a ketene dithioacetal structure. Current Medicinal Chemistry-Anti-Infective Agents, 2003, 2(2), 147-160.
56. Jones, B. M.; Geary, I.; Lee, M. E.; Duerden, B. I. Comparison of the in vitro activities of Fenticonazole, other imidazoles, Metronidazole, and Tetracycline against organisms associated with bacterial vaginosis and skin infections. Antimicrob. Agents Chemother, 1989, 33(6), 970-972.
57. Leung, C. Y. Antifungal therapy in dermatology. Journal of the Hong Kong Medical Association, 1990, 42(4), 203-205.
58. Lackner, T. E.; Clissold, S. P. Bifonazole: A review of its antimicrobial and therapeutic use in superficial mycoses. Drugs, 1989, 38(2), 204-225.
59. Stewart, J. C. M.; Ferguson, J; Davey, P. New antifungal and antiviral chemotherapy. Brit. Med. J, 1983, 286, 1802-1805.
60. Sawyer, Phyllis R.; Brogden, R. N.; Pinder, R. M.; Speight, T. M.; Avery, G. S. Miconazole: A review of its antifungal activity and therapeutic efficacy. Drugs, 1975, 9(6), 406-423.
61. Odds, F. C.; Webster, C. E.; Abbott, A. B. Antifungal relative inhibition factors: BAY 1-9139, Bifonazole, Butoconazole, Isoconazole, Itraconazole (R 51211), Oxiconazole, Ro 14-4767/002, Sulconazole, Terconazole and Vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents. J. Antimicrob. Chemother, 1984, 14, 105-114.
62. Sawyer, Phyllis R.; Brogden, R. N.; Pinder, R. M.; Speight, T. M.; Avery, G. S. Clotrimazole: A review of its antifungal activity and therapeutic efficacy. Drugs, 1975, 9(6), 424-447.
63. Heel, R. C.; Brogden, R. N.; Speight, T. M.; Avery, G. S. Econazole: A review of its antifungal activity and therapeutic efficacy. Drugs, 1978, 16(3), 177-201.
64. Torres-RodriGuez, J. M.; Mendez, R.; Lo, O.; Morera, Y.; Espasa, M.; Jimenez, T.; Lagunas, C. In Vitro susceptibilities of clinical yeast isolates to the new antifungal Eberconazole compared with their susceptibilities to Clotrimazole and Ketoconazole. Antimicrob. Agents Chemother, 1999, 43(5), 1258-1259.
65. Fernandez-Torres, B.; Inza, I.; Guarro, J. Evaluation of disk diffusion method for determining Eberconazole susceptibility of dermatophytes and influence of culture medium. Antimicrob. Agents Chemother, 2005, 49(5), 2116-2118.
66. Barugl, D.; Groot, K. D. Effect of the imidazole derivative Lombazole on the ultrastructure of Staphylococcus epidermidis and Candida albicans. Antimicrob. Agents Chemother, 1985, 28(5), 643-647.
67. Shih, S. R.; Tsai, M. C.; Tseng, S. N.; Won, K. F.; Shia, K. S.; Li, W. T.; Chern, J. H.; Chen, G. W.; Lee, C. C.; Lee, Y. C.; Peng, K. C.; Chao, Y. S. Mutation in enterovirus 71 capsid protein vp1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother, 2004, 48(9), 3523-3529.
68. Castellano, S.; Stefancich, G.; Chillotti, A.; Poni, G. Synthesis and antimicrobial properties of 3-aryl-1-(1, 1-biphenyl-4-yl)-2-(1Himidazol-1-yl)propanes as 'carba-analogues' of the N-arylmethyl-N-[(1, 1-biphenyl)-4-ylmethyl])-1H-imidazol-1-amines, a new class of antifungal agents. Il Farmaco, 2003, 58, 563-568.
69. Setzu, M. G.; Stefancich, G.; Colla, P. L.; Castellano, S. Synthesis and antifungal properties of N-[(1, 1-biphenyl)-4-ylmethyl]-1Himidazol-1-amine derivatives. Il Farmaco, 2002, 57, 1015-1018.
70. Hori, K.; Sakaguchi, A.; Kudoh, M.; Ishida, K.; Aoyama, Y.; Yoshida, Y. Structure-activity relationships of a new antifungal imidazole, AFK-108, and related compounds. Chem. Pharm. Bull, 2000, 48(1), 60-64.
71. Emami, S.; Foroumadi, A.; Falahati, M.; Lotfali, E.; Rajabalian, S.; Ebrahimi, S. A.; Farahyar, S.; Shafiee, A. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents. Bioorg. Med. Chem. Lett, 2008, 18, 141-146.
72. Santo, R. D.; Tafi, A.; Costi, R.; Botta, M.; Artico, M.; Corelli, F.; Forte, M.; Caporuscio, F.; Angiolella, L.; Palamara, A. T. Antifungal Agents. 11. N-substituted derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: Synthesis, anti-Candida activity, and QSAR Studies. J. Med. Chem, 2005, 48, 5140-5153.
73. Dorota, M. Modelling of antifungal activity of some imidazoles. Acta. Pol. Pharm, 1999, 56(5), 381-384.
74. Singh, P.; Daniel, V.; Nema, R. K.; Joshi, A.; Bhatt, G. Synthesis and in-vitro anti-microbial activity of some new NPhenylacetamide derivatives. Int. J. Pharm. Clin. Res, 2009, 1(3), 150-152.
75. Walker, K. A. M.; Braemer, A. C.; Hitt, S.; Jones, R. E.; Matthews, T. R. 1-[4-(4-Chloropheny1)-2-(2, 6-dichlorophenylthio)-N-butyl]-1H-imidazole nitrate, a new potent antifungal agent. J. Med. Chem, 1978, 21(8), 840-843.
76. Botta, M.; Corelli, F.; Manetti, F.; Mugnaini, C.; Andrea, T. Rational design and synthesis of homochiral azole antifungal agents. Pure appl. Chem, 2001, 73(9), 1477-1485.
77. Tafi, A.; A, Jane, T. T.; Botta, M.; Corelli, F.; Massa, S.; Artico, M.; Costi, R.; Santo, R. D.; Ragno, R. Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study. J. Med. Chem, 1996, 39, 1227-1235.
78. Lovey, R. G.; Elliott, A. J.; Kaminski, J. J.; Loebenberg, D.; Parmegiani, R. M.; Rane, D. F.; Girijavallabhan, V. M.; Pike, R. E.; Guzik, H.; Antonacci, B.; Tomaine, T. Y.; Isobenzofurans as conformationally constrained Miconazole analogues with improved antifungal potency. J. Med. Chem, 1992, 35, 4221-4229.
79. 14DM by molecular docking and MM/PBSA method. Bioorg. Med. Chem, 2007, 15, 7444-7458.
80. Mullen, G. B.; DeCory, T. R.; Mitchell, J. T.; Allen, S. D.; Kinsolving, C. R.; Georgiev, V. S. Studies on Antifungal Agents. 23. Novel substituted 3, 5-Diphenyl-3-(1H-imidazol-1-ylmethy1)-2-alkylisoxazolidine derivatives. J. Med. Chem, 1988, 31, 2008-2014.
81. Ogata, M.; Matsumoto, H.; Hamada, Y.; Takehara, M.; Tawara, K. 1-[1-[2-[(3-Chlorobenzyl)oxy]phenyl]vinyl]-lH-imidazole Hydrochloride, a new potent antifungal agent. J. Med. Chem, 1983, 26, 768-770.
82. Cutsem, J. V.; Borgers, M.; Brabander, M. D. The activity of Ketoconazole in clinical isolates of Candida albicans cultured in a mycelium promoting medium. Mykosen, 1981, 24(10), 596-602.
83. Dyer, R. L.; Ellames, G. J.; Hamill, B. J.; Manley, P. W.; Pope A. M. S. Synthesis of (E)-1-(5-Chlorothien-2-y1)-2-(1H-imidazol-1-y1)ethanone-2, 6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent. J. Med. Chem, 1983, 26, 442-445.
84. Henrv, M. J.; Sisler H. D. Effects of Miconazole and dodecylimidazole on sterol biosynthesis in Ustilago maydis. Antimicrob. Agents Chemother, 1979, 15, 603-607.
85. Bossche, H. V. D.; Willemsens, G.; Cools, W.; Cornelissen, F.; Lauwers, W. F. J.; Cutsem, J. M. V. In vitro and in vivo effects of the antimycotic drug Ketoconazole on sterol synthesis. Antimicrob. Agents Chemother, 1980, 17(6), 922-928.
86. Ogata, M.; Matsumoto, H.; Shimizu, S.; Kida, S.; Shiro, M.; Tawara, K. Synthesis and antifungal activity of new 1-Vinylimidazoles. J. Med. Chem, 1987, 30, 1348-1354.
87. Silvestri, R.; Artico, Marino; Regina, G. L.; Pasquali, A. D.; Martino, G. D.; D'Auria, F. D.; Nencioni, L.; Palamara, A. T. Imidazole analogues of Fluoxetine, a novel class of anti-Candida agents. J. Med. Chem, 2004, 47, 3924-3926.
88. Artico, M.; Santo, R. D.; Costi, R.; Massa, S.; Retico, A.; Artico, M.; Apuzzo, G.; Simonetti, S. G.; Strippolis, V. Antifungal agents. 9. 3-Aryl-4-[-1(H-imidazol-l-l)aryl methyl]pyrroles: A new class of potent anti-Candida Agents. J. Med. Chem, 1995, 38, 4223-4233.
89. Aninat, C.; Hayashi, Y.; Andre, F.; Delaforge, M. Molecular requirements for inhibition of cytochrome P450 activities by Roquefortine. Chem. Res. Toxicol, 2001, 14, 1259-1265.
90. Saha, A. K.; Liu, L.; Simoneaux, R. L.; Kukla, M. J.; Marichal, P.; Odds F. Novel antifungals based on 4-substituted imidazole: A combinatorial chemistry approach to lead discovery and optimization. Bioorg. Med. Chem. Lett, 2000, 10, 2175-2178.
91. Hussain, T.; Siddiqui, H. L.; Zia-ur-Rehman, M.; Yasinzai, M. M.; Parvez, M. Anti-oxidant, anti-fungal and anti-leishmanial activities of novel 3-[4-(1H-imidazol-1-yl)phenyl]prop-2-en-1-ones. Eur. J. Med. Chem, 2009, 44, 4654-4660.
92. Sharma, S.; Gangal, S.; Rauf, A. Convenient one-pot synthesis of novel 2-substituted benzimidazoles, tetrahydrobenzimidazoles and imidazoles and evaluation of their in vitro antibacterial and antifungal activities. Eur. J. Med. Chem, 2009, 44, 1751-1757.
93. 1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1, 2, 4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: A combined experimental and computational approach. ARKIVOC, 2004, V, 231-250.
94. Karakurt, A.; Dalkara, S.; Meral, O.; Suheyl, O.; Kendi, E.; Stables, J. P. Synthesis of some 1-(2-naphthyl)-2-(imidazole-1-yl) ethanoneoxime and oxime ether derivatives and their anticonvulsant and antimicrobial activities. Eur. J. Med. Chem, 2001, 36, 421-433.
95. Gundogdu-Karaburun, N.; Benkli, K.; Tunali, Y.; Uçucu, U.; Demirayak, S. Synthesis and antifungal activities of some aryl[3-(imidazol-1-yltriazol-1-ylmethyl)benzofuran-2-yl] ketoximes. Eur. J. Med. Chem, 2006, 41, 651-656.
96. Na, Y. M.; Borgne, M. L.; Pagniez, F.; Le, B. G.; Pape, P. L. Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives. Eur. J. Med. Chem, 2003. 38, 75-87.
97. Rossello, A.; Bertini, S.; Lapucci, A.; Macchia, M.; Martinelli, A.; Rapposelli, S.; Herreros, E.; Bruno, M. Synthesis, antifungal activity, and molecular modeling studies of new inverted oxime ethers of Oxiconazole. J. Med. Chem, 2002, 45, 4903-4912.
98. Ogura, H.; Kobayashi, H.; Nagai, K.; Nishida, T.; Naito, T.; Tatsumi, Y.; Yokoo M.; Arika, T. Synthesis and antifungal activities of (2R, 3R)-2-Aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives as topical antifungal agents. Chem. Pharm. Bull, 1999, 47(10), 1417-1425.
99. Heeres, J.; Backx, L.; Cutsem, J. Synthesis and antimycotic properties of l-(2-Alkyl-2-phenylethyl)-1H-imidazoles. J. Med. Chem, 1976, 19(9), 1148-1155.
100. Heeres, J.; Mostmans, J. H.; Cutsem, J. V. Antimycotic imidazoles. 2. Synthesis and antimycotic properties of 1-[2-(Arylalkyl)-2-phenylethyl]-lH-imidazoles. J. Med. Chem, 1977, 20(11), 1511-1516.
101. Heeres, J.; Cutsem, J. V. Antimycotic imidazoles. 5. Synthesis and antimycotic properties of 1-[2-Aryl-4-(arylalkyl)-1, 3-dioxolan-2-yl]methyl]1-H-imidazoles. J. Med. Chem, 1981, 24, 1360-1364.
102. Heeres, J.; Backx, L. J. J.; Cutsem, J. V. Antimycotic imidazoles. 3. Synthesis and antimycotic properties of 1-[2-(Aryloxyalkyl)-2-phenylethyl]-1H-imidazoles. J. Med. Chem, 1977, 20(11), 1516-1520.
103. Walker, K. A. M.; Hirschfeld, D. R.; Marx, M. Antimycotic imidazoles. 2. Synthesis and antifungal properties of esters of 1-[2-Hydroxy(mercapto)-2-phenylethyl]-1H-imidazoles. J. Med. Chem, 1978, 21(12), 1335-1338.
104. Regina, G. L.; Auria, F. D.; Tafi, A.; Piscitelli, F.; Olla, S.; Caporuscio, F.; Nencioni, L.; Cirilli, R.; Torre, F. L.; Melo, N. R. D.; Kelly, S. L.; Lamb, D. C.; Artico, M.; Botta, M.; Palamara, A. T.; Silvestri, R. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies. J. Med. Chem, 2008, 51, 3841-3855.
105. Menozzi, G.; Merello, L.; Fossa, P.; Schenone, S.; Ranise, A.; Mosti, L.; Bondavalli, F.; Loddo, R.; Murgioni, C.; Mascia, V.; Colla, P. L.; Tamburini, E. Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1, 5-diphenyl-1H-pyrazoles. Bioorg. Med. Chem, 2004, 12, 5465-5483.
106. Niwano, Y.; Ohmi, T.; Seo, A.; Kodama, H.; Koga, H.; Sakai, A. Lanoconazole and its related optically active compound NND-502: Novel antifungal imidazoles with a ketene dithioacetal structure. Curr. Med. Chem.-Anti-Infective Agents, 2003, 2, 147-160.
107. Luca, L. D. Naturally Occurring and Synthetic Imidazoles: Their chemistry and their biological activities. Current Medicinal Chemistry, 2006, 13, 1-23.
108. Niwano, Y.; Kuzuhara, N.; Kodama, H.; Yoshida, M.; Miyazaki, T.; Yamaguchi, H. In Vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Antimicrob. Agents Chemother, 1998, 42(4), 967-970.
109. Niwano, Y.; Kuzuhara, N.; Goto, Y.; Munechika, Y.; Kodama, H.; Kanai, K.; Yoshida, M.; Miyazaki, T.; Yamaguchi, H. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections. Int. J. Antimicrob. Agents, 1999, 12, 221-228.
110. Uchida, K.; Nishiyama, Y.; Tanaka, T.; Yamaguchi, H. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. Int. J. Antimicrob. Agents, 2003, 21, 234-238.
111. Chevreuil, F.; Landreau, A.; Seraphin, D.; Larcher, G.; Bouchara, J.; Richomme P. Synthesis and antifungal activity of new thienyl and aryl conazoles. J. Enzym. Inhib. Med. Chem, 2006, 21(3), 293-303.
112. Emami, S.; Behdad, M.; Foroumadi, A.; Falahati, M.; Lotfali, E.; Sharifynia, S. Design of conformationally constrained azole antifungals: Efficient synthesis and antifungal activity of trans-3-imidazolylflavanones. Chem Biol Drug Des, 2009, 73, 388-395.
113. Chevreuil, F.; Landreau, A.; Seraphin, D.; Larcher, G.; Bouchara, J.; Richomme, P. Synthesis of new 1-[2-Azido-2-(2, 4-dichlorophenyl) ethyl]-1H/-imidazoles and in vitro evaluation of their antifungal activity. J. Enzym. Inhib. Med. Chem, 2008, 23(5), 617-622.
114. Mamolo, M. G.; Zampieri, D.; Falagiani, V.; Vio, L.; Banfi, E. Synthesis and antifungal activity of (±)-1-(5-aryl-3-pyridin-2-yl-4, 5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives. Il Farmaco, 2003, 58, 315-322.
115. Zampieri, D.; Mamolo, M. G.; Laurini, E.; Scialino, G.; Banfi, E.; Vio, L. Antifungal and antimycobacterial activity of 1-(3, 5-diaryl-4, 5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. Bioorg. Med. Chem, 2008, 16, 4516-4522.
116. Menozzi, G.; Mosti, L.; Fossa, P.; Musiu, C.; Murgioni, C.; Colla, PL. Synthesis and biological evaluation of azole derivatives, analogues of Bifonazole, with a phenylisoxazolyl or phenylpyrimidinyl moiety. Il Farmaco, 2001, 56, 633-640.
117. Nakamura, S. Structure of Azomycin, a new antibiotic. Chem. Pharm. Bull, 1955, 3, 379-383.
118. Sabaa, M. W.; Mohamed, N. A.; Mohamed, R. R.; Khalil, N. M.; Latif, S. M.; Abd E. Synthesis, characterization and antimicrobial activity of poly(N-vinyl imidazole) grafted carboxymethyl chitosan. Carbohyd. Polym, 2010, 79, 998-1005.
119. Tafi, A.; Costi, R.; Botta, M.; Santo, R. D.; Corelli, F.; Massa, S.; Ciacci, A.; Manetti, F.; Artico, M. Antifungal agents. 10. New derivatives of 1-[(Aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-Candida activity, and quantitative structure-analysis relationship studies. J. Med. Chem, 2002, 45, 2720-2732.
120. Nagababu, P.; Latha, J. N.; Pallavi, P.; Harish, S.; Satyanarayana, S. Studies on antimicrobial activity of cobalt(III) ethylenediamine complexes. Can. J. Microbiol, 2006, 52, 1247-1254.
121. Garg, G.; Chauhan, G. S.; Gupta, R.; Ahn, J. H. Anion effects on antimicrobial activity of poly[1-vinyl-3-(2-sulfoethylimidazoliumbetaine)]. J. Colloid Interf. Sci, 2010, 344, 90-96.
122. Heeres J.; Backx, J. J.; Mostmans, J. H.; Custem, J. V. Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of Ketoconazole, a new potent orally active broad spectrum antifungal agent. J. Med. Chem, 1979, 22(8), 1003-1005.
123. Rodri{dotless}guez-Arguelles, M. C.; Lopez-Silva, E. C.; Sanmarti{dotless}n, J.; Bacchi, A.; Pelizzi, C.; Zani, F. Cobalt and nickel complexes of versatile imidazole-and pyrrole-2-carbaldehyde thiosemicarbazones. Synthesis, characterisation and antimicrobial activity. Inorganica Chimica Acta, 2004, 357, 2543-2552.
124. Wang, Y.; Tang, G.; Zhang, Y.; Wan, W.; Yu, J.; Li, T.; Cui, Y. A new 2-D cobalt coordination polymer with the flexible 2-(1Himidazole-1-yl)acetate: Synthesis, structure, and characterization. J. Coord. Chem, 2010, 63(9), 1504-1513.
125. Servi, S.; Genc, M.; Gur, S.; Koca, M. The synthesis and antimicrobial activity of some new methyl N-arylthiocarbamates, dimethyl N-aryldithiocarbonimidates and 2-arylamino-2-imidazolines. Eur. J. Med. Chem, 2005, 40, 687-693.
126. Pahwa, S.; Chavan, A. G.; Jain, R.; Roy, N. Target-specific antifungal discovery by targeting Geotrichum candidum histidinol dehydrogenase: A hybrid approach. Chem. Biol. Drug Des, 2008, 72, 229-234.
127. Saha, A. K.; Liu, L.; Marichal, P.; Odds, F. Novel antifungals based on 4-substituted imidazole: Solid-phase synthesis of substituted aryl sulfonamides towards optimization of in vitro activity. Bioorg. Med. Chem. Lett, 2000, 10, 2735-2739.
128. Sharma, D.; Narasimhan, B.; Kumar, P.; Judge, V.; Narang, R.; Clercq, E. D.; Balzarini, J. Synthesis, antimicrobial and antiviral evaluation of substituted imidazole Derivatives. Eur. J. Med. Chem, 2009, 44, 2347-2353.
129. Demberelnyamba, D.; Kim, K. S.; Choi, S.; Park, S. Y.; Lee, H.; Kimb, C. J.; Yoob, I. D. Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts. Bioorg. Med. Chem, 2004, 12, 853-857.
130. Carroll, A. R.; Duffy, S.; Avery, V. M. Citronamides A and B, tetrapeptides from the australian sponge Citronia astra. J. Nat. Prod, 2009, 72, 764-768.
131. Godefroi, E. F.; Geenen, J. J. H. 2-Phenethylimidazole derivatives. Synthesis and antimycotic properties. J. Med. Chem, 1975, 18(5), 530-533.
132. Demirayaka, S; Benklia, K.; Guvenb, K. Synthesis and antimicrobial activities of some 3-arylamino-5-[2-(substituted-1-imidazolyl)ethyl]-1, 2, 4-triazole derivatives. Eur. J. Med. Chem, 2000, 35, 1037-1040.
133. Devadas, B.; Freeman, S. K.; Zupec, M. E.; Lu, H. F.; Nagarajan, S. R.; Kishore, N. S.; Lodge, J. K.; Kuneman, D. W.; McWherter, C. A.; Vinjamoori, D. V.; Getman, D. P.; Gordon, J. I.; Sikorski, J. A. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans Myristoyl CoA: Protein N-Myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. J. Med. Chem, 1997, 40, 2609-2625.
134. Dahiya, R.; Mourya, R.; Agrawal, S. C. Synthesis and antimicrobial screening of peptidyl derivatives of bromocoumarins/methylimidazoles. African Journal of Pharmacy and Pharmacology, 2010, 4(5), 214-225.
135. Liesen, A. P.; Aquino, T. M.; Carvalho, C. S.; Lima, V. T.; Araújo, J. M.; Lima, J. G.; Faria, A. R.; Melo, E. J. T; Alves, A. J.; Alves, E. W.; Alves, A. Q.; Góes, A. J. S. Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1, 3, 4-thiadiazoles. Eur. J. Med. Chem, 2010, 45(9), 3685-3691.
136. Das, P.; Himaja, M. Design and synthesis Of 4-[2-(5-Nitro)]imidazolylbenzoyl(N-methyl)aminoacids and peptides. Int. J. Drug Develop. Res, 2010, 2(2), 364-370.
137. Lakshmanan, B.; Mazumder, P. M.; Sasmal, D.; Ganguly, S. Biologically active azoles: Synthesis, characterization and antimicrobial activity of some 1-substituted imidazoles. Der Pharmacia Lettre, 2010, 2(4), 82-89.
138. Sakemi, S.; Sun, H. H. Nortopsentins A, B, and C. Cytotoxic and antifungal imidazolediyl-bis[indoles] from the sponge Spongosorites ruetzleri. J. Org. Chem, 1991, 56, 4304-4307.
139. Dahiya, R.; Kumar, A.; Yadav, R. Synthesis and biological activity of peptide derivatives of Iodoquinazolinones/Nitroimidazoles. Molecules, 2008, 13, 958-976.
140. Cavalleri, B.; Ballotta, R.; Arioli, V.; Lancini, G. New 5-substituted 1-Alkyl-2-nitroimidazoles. J. Med. Chem, 1973, 16(5), 557-560.
141. Rowan, R.; Tallon, T.; Sheahan, A. M.; Curran, R.; McCann, M.; Kavanagh, K.; Devereux, M.; McKee, V. 'Silver bullets' in antimicrobial chemotherapy: Synthesis, characterisation and biological screening of some new Ag(I)-containing imidazole complexes. Polyhedron, 2006, 25, 1771-1778.
142. Joseyphus, R. S.; Nair, M. S. Synthesis, characterization and antimicrobial activity of transition metal complexes with the schiff base derived from imidazole-2-carboxaldehyde and glycylglycine. J. Coord. Chem, 2009, 2(2), 319-327.
143. Pittillo, R. F.; Hunt, D. E. Broad Spectrum antimicrobial activity of a new triazenoimidazole. Appli. Microbiol, 1967, 15(3), 531-532.
144. Rufer, C.; Kessler, H. J.; Schroder, E. Chemotherapeutic nitroheterocycles. 6. Substituted 5-Aminomethyl-3-(5-nitro-2-imidazolylmethyleneamino)-2-oxazolidinones. J. Med. Chem, 1971, 14(2), 94-96.
145. Raghavendra, N. M.; Thampi, P.; Gurubasavarajaswamy, P. M.; Sriram, D. Synthesis and antimicrobial activities of some novel substituted 2-Imidazolyl-N-(4-oxo-quinazolin-3(4H)-yl)-acetamides. Chem. Pharm. Bull, 2007, 55(11), 1615-1619.
146. Sharma, R. K.; Reddy, R. P.; Tegge, W.; Jain, R. Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides. J. Med. Chem, 2009, 52, 7421-7431.
147. Dahiya, R. Synthesis, Characterization and antimicrobial studies on some newer imidazole analogues. Sci Pharm, 2008, 76, 217-239.
148. Sadashiva, M. P.; Mallesha, H.; Hitesh, N. A.; Rangappa, K. S. Synthesis and microbial inhibition study of novel 5-imidazolyl substituted isoxazolidines. Bioorg. Med. Chem, 2004, 12, 6389-6395.
149. Cavalleri, B.; Volpe, G.; Arioli, V. Synthesis and biological activity of some Vinyl-substituted 2-nitroimidazoles. J. Med. Chem, 1977, 20(5), 656-660.
150. Beaman, A. G.; Tautz, W.; Gabriel, T.; Keller, O.; Toome, V.; Duschinsky, R. Studies in the nitroimidazole series. I. Synthesis of Azomycin A and related compounds. Antimicrob. Agents Chemother, 1965, 469-477.
151. Banfi, E.; Scialino, G.; Zampieri, D.; Mamolo, M. G.; Vio, L.; Ferrone, M.; Fermeglia, M.; Paneni, M. S.; Pricl, S. Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. J. Antimicrob. Chemother, 2006, 58, 76-84.
152. Srivastava, P. C.; Streeter, D. G.; Matthews, T. R.; Allen, L. B.; Sidwell, R. W.; Robins, R. K. Synthesis and antiviral and antimicrobial activity of certain 1-β-Ribofuranosyl-4, 5-disubstituted imidazoles. J. Med. Chem, 1976, 19(8), 1020-1026.
153. Gursoy, A.; Iyikosker, T.; Terzioglu, N.; Otuk, G. Synthesis and antimicrobial evaluation of some novel imidazolylmercaptoacetylthiosemicarbazide and 4-thiazolidinone analogues. Turkish J. Pharm. Sci, 2005, 2(1), 1-10.
154. Tweit, R. C.; Kreider, E. M.; Muir, R. D. Synthesis of antimicrobial Nitroimidazolyl-2-sulfides, sulfoxides, and sulfones. J. Med. Chem, 1973, 16(10), 1161-1169.
155. Roue, M.; Domart-Coulon, I.; Ereskovsky, A.; Djediat, C.; Perez, T.; Bourguet-Kondracki, M. L. Cellular localization of clathridimine, an antimicrobial 2-aminoimidazole alkaloid produced by the mediterranean calcareous sponge Clathrina clathrus. J. Nat. Prod, 2010, 73, 1277-1282.
156. Khan, M. S.; Siddiqui, S. A.; Siddiqui, M. S.; Goswami, U.; Srinivasan K. V.; Khan, M. I.; Antibacterial activity of synthesized 2, 4, 5-trisubstituted imidazole derivatives. Chem Biol Drug Des, 2008, 72, 197-204.
157. El-Barbary, A. A.; El-Ezz, A. Z. A.; Sharaf, A. M.; Nielsen, C. Studies on 2, 4-dithioxo and 2-thioxoimidazolidene derivatives. Phosphorus, Sulfur, and Silicon, 2007, 182, 1621-1632.
158. Rufer, C.; Kessler, H. J.; Schroder, E. Chemotherapeutic nitroheterocycles. 18. 2-(5-Nitro-2-imidazolylmethylene-)-1-indanones,-1-tetralones, and-acetophenones substituted by aminoalkoxy groups. J. Med. Chem, 1975, 18(3), 253-258.
159. Anthony, N. G.; Breen, D.; Clarke, J.; Donoghue, G.; Drummond, A. J.; Ellis, E. M.; Gemmell, C. G.; Helesbeux, J. J.; Hunter, I. S.; Khalaf, A. I.; Mackay, S. P.; Parkinson, J. A.; Suckling, C. J.; Waigh, R. D. Antimicrobial Lexitropsins containing amide, amidine, and alkene linking groups. J. Med. Chem, 2007, 50, 6116-6125.
160. Sadashiva, M. P.; Mallesha, H.; Murthy, K. K.; Rangappa, K. S. Enhancement in antimicrobial activity of 2-(phenyl)-3-(2-butyl-4-chloro-1H-imidazolyl)-5-butylate isoxazolidines. Bioorg. Med. Chem. Lett, 2005, 15, 1811-1814.
161. El-Din, A. A. M.; Roaiah, H. F.; Elsharabasy, S. A.; Hassan, A. Y. A novel synthesis of some new imidazothiazole and glycocyamidine derivatives and studies on their antimicrobial activities. Phosphorus, Sulfur, and Silicon, 2007, 182, 529-536.
162. Varoli, L.; Burnelli, S.; Garuti, L.; Vitali, B. Synthesis and antimicrobial activity of new diazoimidazole derivatives containing an N-acylpyrrolidine ring, Il Farmaco, 2001, 56, 885-890.
163. Dawane, B. S.; Konda, S. G.; Khandare, N. T.; Chobe, S. S.; Shaikh, B. M.; Bodade, R. G.; Joshi, V. D. Synthesis and antimicrobial evaluation of 2-(2-butyl-4-chloro-1H-imidazol-5-yl-methylene)-substituted-benzofuran-3-one. Org. Commun, 2010, 3(2), 22-29.
164. Frank, V. P.; Kalluraya, B. Synthesis of 1, 3, 4-oxadiazoles carrying imidazole moiety. Indian J. Chem, 2005, 44B, 1456-1459.
165. Khabnadideh, S.; Rezaei, Z.; Khalafi-Nezhad, A.; Pakshir, K.; Heiran, M. J.; Shobeiri, H. Design and synthesis of 2-Methyl and 2-Methyl-4-nitro imidazole derivatives as antifungal agents. Iranian J. Pharm Sci, 2009, 5(1), 31-36.
166. Husain, A.; Drabu, S.; Kumar, N. Synthesis and biological screening of di-and trisubstituted imidazoles. Acta Pol Pharm-Drug Research, 2009, 66(3), 243-248.
167. Frank, P. V.; Girish, K. S.; Kalluraya, B. Solvent-free microwaveassisted synthesis of oxadiazoles containing imidazole moiety. J. Chem. Sci, 2007, 119(1), 41-46.
168. Kumar, L.; Sarswat, A.; Lal, N.; Sharma, V. L.; Jain, A.; Kumar, R.; Verma, V.; Maikhuri, J. P.; Kumar, A.; Shukla, P. K.; Gupta, G. Imidazole derivatives as possible microbicides with dual protection. Eur. J. Med. Chem, 2010, 45, 817-824.
169. Dawane, B. S.; Konda, S. G.; Mandawad, G. G.; Shaikh, B. M. Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation. Eur. J. Med. Chem, 2010, 45, 387-392.
170. Demirayak, S.; Karaburun, A. C.; Kiraz, N. Synthesis and antibacterial activities of some 1-[2-(substituted pyrrol-1-yl)ethyl]-2-methyl-5-nitroimidazole derivatives. Eur. J. Med. Chem, 1999, 34, 275-278.
171. Khabnadideh, S.; Rezaei, Z.; Khalafi-Nezhad, A.; Bahrinajafi, R.; Mohamadi, R.; Farrokhroz, A. A. Synthesis of N-alkylated derivatives of imidazole as antibacterial agents. Bioorg. Med. Chem. Lett, 2003, 13, 2863-2865.
172. Gunay, N. S.; Capan, G.; Ulusoy, N.; Ergenc, N.; Otuk, G.; Kaya, D. 5-Nitroimidazole derivatives as possible antibacterial and antifungal agents. Il Farmaco, 1999, 54, 826-831.
173. Tweit, R. C.; Muir, R. D.; Ziecina, S. Nitroimidazoles with antibacterial activity against Neisseria gonorrhoeae. J. Med. Chem, 1977, 20(12), 1697-1700.
174. Srivastava, P. C.; Newman, A. R.; Matthews, T. R.; Robins, R. K. Synthesis of 5-amino-1-(5-deoxy-β-D-ribofuranosyl)imidazole-4-carboxamide and related 5-deoxyimidazole ribonucleosides. J. Med. Chem, 1975, 18(12), 1237-1240.
175. Rufeh, C.; Kessler, H. J.; Schroder, E. Chemotherapeutic Nitroheterocycles 7. Substituted 5-Alkylthiomethy1-3-(5-nitro-2-imidazolyl)methyleneamino-2-oxazolidinones. J. Med. Chem, 1971, 14(10), 934-935.
176. Patel, P. S.; Shah, R. A.; Trivedi, D. K.; Vyas, P. J. Synthesis, characterization and antimicrobial activity of 1-acetyl-5-(substitutedphenyl)-{3-[4-(2-methyl-4-benzylidene-5-oxoimidazol-1-yl)]phenyl}-4, 5-dihydro pyrazol. Der Pharma Chemica, 2010, 2(1), 168-172.
177. Shams, H. Z.; Mohareb, R. M.; Helal, M. H.; Mahmoud, A. E. Synthesis, structure elucidation, and biological evaluation of some fused and/or pendant thiophene, pyrazole, imidazole, thiazole, triazole, triazine, and coumarin systems based on cyanoacetic 2-[(Benzoylamino)thioxomethyl]hydrazide. Phosphorus, Sulfur, and Silicon, 2007, 182(2), 237-263.
178. De, B.; Gupta, J. K.; Saravanan, V. S. Synthesis of some oxazolinones and imidazolinones and their antimicrobial screening. Acta Pharm, 2005, 55, 287-296.
179. El-Sharief, A. M. S.; Moussa, Z. Synthesis, characterization and derivatization of some novel types of mono-and bisimidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities-part I. Eur. J. Med. Chem, 2009, 44, 4315-4334.
180. Amir, M.; Kumar, A.; Ali, I.; Khan, S. A. Synthesis of pharmaceutically important 1, 3, 4-thiadiazole and imidazolinone derivatives as antimicrobials. Indian J. Chem, 2009, 48B, 1288-1293.
181. El-Sharief, A. M. S.; Al-Amria, A. M.; Al-Raqaa, S. Y. Halogenated, alkylated and new types of imidazolidine, pyrrolidine, imidazotriazine and thienoimidazole derivatives with biological and antitumor activities. J. Sulfur Chem, 2006, 27(3), 245-263.
182. Jayashankara, B.; Rai, K. M. L. Synthesis and antimicrobial studies of a new series of bis-heterocycles. E-J Chem, 2008, 5(2), 370-376.
183. Jayashankara, B.; Rai, K. M. L. Synthesis and antimicrobial studies of new series of pyrazoline bearing bis-heterocycles via 1, 3-dipolar cycloaddition reactions. E-J. Chem, 2008, 5(2), 309-315.
184. Matysiak, J.; Niewiadomy, A.; Krajewska-Kulak, E.; Macik-Niewiadomy, G. Synthesis of some 1-(2, 4-dihydroxythiobenzoyl) imidazoles,-imidazolines and-tetrazoles and their potent activity against Candida species. Il Farmaco, 2003, 58, 455-461.
185. Yasodha, A.; Sivakumar, A.; Arunachalam, G.; Puratchikody, A. Synthesis and biological evaluation of some 2, 4, 5-triphenyl imidazole derivatives. J. Pharm. Sci. Res, 2009, 1(4), 127-130.
186. Patel, A.; Bari, S.; Takele, G.; Patel, J.; Sarangapani M. Synthesis and antimicrobial activity of some new Isatin derivatives. Iranian J. Pharm. Res, 2006, 4, 249-254.
187. Maddila, S.; Palakondu, L.; Chunduri, V. R. Synthesis, antibacterial, antifungal and antioxidant activity studies on 2-benzylthio-and 2-benzylsulfonyl-1H-imidazoles. Der Pharmacia Lettre, 2010, 2(4), 393-402.
188. Khan, K. M.; Mughal, U. R.; Khan, S.; Khan, S.; Perveen S.; Choudhary, M. I. Synthesis and antibacterial and antifungal activity of 5-substituted imidazolones. Letters in Drug Design and Discovery, 2009, 6, 69-77.
189. Nagarapu, L.; Satyender, A.; Rajashaker, B.; Srinivas, K.; Rani, P. R.; Radhika, K.; Subhashini, G. Synthesis and antimicrobial activity of novel C-linked imidazole glycoconjugates. Bioorg. Med. Chem. Lett, 2008, 18, 1167-1171.
190. Baldaniya, B. B. Synthesis, characterization and biological activity of 5-Arylidene-3-(6, 7-dicloro-1, 3-benzothiazol-2-yl)-phenyl-3, 5-dihydro-4H-imidazol-4-ones. E-J. Chem, 2010, 7(1), 81-84.
191. Ghorab, M. M.; Radwan, M. A. A.; Taha, N. M. H.; Amin, N. E.; Shehab, M. A.; Faker, M. I. Dapson in heterocyclic chemistry, Part II: Antimicrobial and antitumor activities of some novel sulfone biscompounds containing biologically active thioureido, carbamothioate, quinazoline, imidazolidine, and thiazole moieties. Phosphorus, Sulfur, and Silicon, 2008, 183, 2906-2917.
192. Godefroi, E. F.; Heeres, J. Ketal derivatives of imidazole. US Patent 3, 575, 999, April 20, 1971.
193. Buchel, K. H.; Regel, E.; Plempel, M. N-Trityl-imidazoles for treating fungal infections. US Patent 3, 655, 900, April, 11, 1972.
194. Buchel, K. H.; Regel, E.; Plempel, M. N-Trityl-imidazoles as antifungal agents. US Patent 3, 660, 577, May, 2, 1972.
195. Hughes, P. G.; Verge, J. P. Oxazole and imidazole derivatives as antifungal agents. US Patent 3, 888, 984, June, 10, 1975.
196. Heeres, J.; Backx, L. J. J.; Mostmans, J. H. 1-(β-Aryl-β-R-ethyl) imidazoles as antimicrobial agents. US Patent 3, 991, 201, November, 9, 1976.
197. Walker, K. A. M.; Marx, M. Imidazol-1-yl propane derivatives. US Patent 4, 036, 973, June, 19, 1977.
198. Walker, K. A. M. Novel 1-Phenethylimidazoles. US Patent 4, 039, 677, August, 2, 1977.
199. Walker, K. A. M. 1-[β-(R-Thio)phenethyl]imidazoles and derivatives thereof. US Patent 4, 055, 652, October, 25, 1977.
200. Walker, K. A. M. Derivatives of substituted N-alkyl imidazoles. US Patent 4, 078, 071, March, 7, 1978.
201. Heeres, J. 1-(2-AR-4-R-1, 3-dioxolan-2-ylmethyl)imidazoles. US Patent 4, 101, 666, July, 18, 1987.
202. Cox, D. A.; Gymer, G. E.; Shroot, B. Antifungal Thioalkylimidazole derivatives. US Patent 4, 107, 314, August, 15, 1978.
203. Walker, K. A. M. Derivatives of N-Alkylimidazoles. US Patent 4, 123, 542, October, 31, 1978.
204. Walker, K. A. M. Derivatives of substituted N-Alkyl imidazoles and compositions and methods containing the same. US Patent 4, 213, 991, July, 22, 1980.
205. Karjalainen, A. J.; Kurkela, K. O. A. Substituted imidazoles and their use. US Patent 4, 333, 947, June, 8, 1982.
206. Martin, J. A. Antifungal Benzofuranyl imidazole compounds. US Patent 4, 402, 968, September, 6, 1983.
207. Sykes, R. A. Synergistic fungal compositions. US Patent 4, 420, 474, December, 13, 1983.
208. Partyka, R. A.; Hudyma, T. W. Sulfur containing imidazoles. US Patent 4, 458, 079, July, 3, 1984.
209. Heeres, J.; Backx, L. J. J.; Mostmans, J. H. Antimicrobial imidazole derivatives. US Patent 4, 483, 865, November, 20, 1984.
210. Komoto, N.; Arai, K.; Hirose, S. Microbicidal 1-[1-(alkoxyphenyl)vinyl]-1H-imidazoles. US Patent 4, 584, 311, April, 22, 1986.
211. Prieto, A. P.; Higom, A. T.; Mata, M. P. C. Antimicrobial salt of Fosfomycin with imidazole. US Patent 4, 675, 315, June, 23, 1987.
212. Klotzer, W.; Link, H.; Mussner, R.; Schiestl, W.; Singewald, N. Antimicrobial 1, 3-disubstituted/imidazolium salts. US Patent 4, 814, 332, March, 21, 1989.
213. Hirota, Y.; Sugiura, H.; Kuroda, N.; Wada T.; Tsujimoto, K. Imidazole derivatives, an antibacterial and antifungal comprising said derivatives, and a process for the production of said imidazole derivatives. US Patent 4, 902, 705, Feburary, 20, 1990.
214. Fujita, T.; Iwasaki, Y.; Yabe, H.; Akita, T. Antifungal and mildew proofing imidazole compounds. US Patent 4, 912, 123, 27, March, 1990.
215. Minoru, T.; Asaoka, T.; Matsuda, H.; Katori, T. Imidazole derivatives. US Patent 5, 082, 948, January, 21, 1992.
216. Paradies, H. H. Imidazole derivatives and use as antibacterial, antifungal and antiviral agents. US Patent 5, 112, 844, May, 12, 1992.
217. Press, J. B.; Sanfilippo, P. Substituted biphenylalkoxyamines. US patent 5192786, March, 9, 1993.
218. Takahi, Y.; Takeshiba, H.; Kato, S.; Tobitsuka, J.; Ohkouchi, T.; Kondo, Y.; Tsuda, M.; Ohta, H. Antimicrobial and antifungal compositions comprising silicon-compounds, and their use in agriculture and horticulture. EP 0609099 A1, August, 3, 1994.
219. Akashi, T.; Tanaka, S.; Sugita, K.; Kohita, H.; Yamagishi, M.; Obata, K. Antifungal agent. US Patent 6, 001, 864, December, 14, 1999.
220. Tepe, J. J.; Peddibhotla, S. Multi-substituted imidazolines and method of use thereof. WO 2003/101969 A1, December, 11, 2003.
221. Tepe, J. J. NF-B inhibitors and uses thereof. WO 2003/101954 A2, December, 11, 2003.
222. Lukacsko, A. B. Compositions and methods for treating body malodor and fungal outgrowth in mammals. US patent 2004/0209954 A1, October, 21, 2004.
223. Huesca, M.; Al-Qawaseh, R.; Young, A. H.; Lee, Y. 2, 4, 5-Trisubstituted imidazoles and their use as anti-microbial agents. WO 2004/016086 A2, Feburary, 26, 2004.
224. Buchalter G. Fabrics impregnated with microbial agents. US Patent 2006/0127457, A1, June, 15, 2006.
225. Tepe, J. J. NF-B inhibitors and uses thereof. WO 2007/133790 A2, November, 22, 2007.
226. Elder, S. T.; Preuss, A.; Schöning, K. U.; Mühlbauer, K. Antimicrobial compositions. WO 2007/144286 A1, December, 21, 2007.
227. Young, M. P.; Yates, C. M.; Idowu, O. C.; Charlton, J. Treatment of multi-drug resistant bacterial infections. WO 2008/059258 A2, May, 22, 2008.
228. Novel imidazole derivatives. EP 2053044 A1, April, 29, 2009.
229. Novel imidazole derivatives. EP 2053045 A1, April, 29, 2009.
230. Raphael, D.; Clemens, L.; Sterphan, T. Novel imidazole derivatives having microbiocidal activity. WO 2009/127615 A1, October, 22, 2009.
231. Jain, R. K.; Low, E.; Francavilla, C.; Shiau, T. P.; Kim, B.; Nair, S. K. Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions. WO 2010/054009 A1, May, 14, 2010.